En el Reino Unido, un estudio sugiere que superar la COVID-19 no sería sinónimo de inmunidad, esta duraría apenas unos meses y el virus podría infectar a a las
En el Reino Unido, un estudio sugiere que superar la COVID-19 no sería sinónimo de inmunidad, esta duraría apenas unos meses y el virus podría infectar a a las personas año tras año como la gripe común. El doctor Elmer Huerta sostuvo que esto podría poner fin a que la 'inmunidad de la manada' sería una manera de luchar contra el coronavirus. [Fuentes: América TV]
:quality(75)/cdn.jwplayer.com/v2/media/gxE6qkOQ/poster.jpg)
:quality(75)/dvgnzpfv30f28.cloudfront.net/07-13-2020/t_c1dc92a49e744bafa44155cc4dd717f8_name_file_640x360_600_v3_.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/jBzLo92P/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/uvAe5PxB/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/ccDVdZbT/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/zkVH73l7/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/ru6pOmZF/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/RMpf2UW4/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/Yh4DJBJ3/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/oB3Cneqn/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/XDHRYGBT4RESZI4ZE2AXO2DWOI.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/D3QIGZJICZHKTKAHS4C2NRRIXI.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/R6SKFHJNSNHUZAUHKVEQRZDCKI.png)
:quality(75)/cdn.jwplayer.com/v2/media/gxE6qkOQ/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/jBzLo92P/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/uvAe5PxB/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/NDT2QQOACNDPXGC3UACYNN6CUA.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/ccDVdZbT/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/Ae3JDX5B/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/QJAPY6IPLJAGVDAQRSYSJVJTNI.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/7KTUUIZWR5F45LIPUIO644CQJM.png)
:quality(75)/cdn.jwplayer.com/v2/media/koNs9MA2/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/6bLTGi5d/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/KgeU8b6Q/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/a6mwPQ4X/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/aIjZ5WWB/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/X3PAJUVAAFHRXHUYV5TON7UAAY.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/juAVPNx9/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/yksVgSj8/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/c0S03whF/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/azLadx4o/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/FQ5XSTUGQ5DI3DYDC3MUSLQL6A.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/9a1H4G0a/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/yOEdb2ys/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/JDVYxTbd/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/LIy1dI2W/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/Xv8iJGpA/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/JW2JBE7IBZEY5NR2VH4KVTPGZ4.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/42WZKDIDGVA6VKQDF75376W2CA.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/ENCJ6JEIFZHT5E6UXK3KZ5RCUU.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/UZ27WLDNBFBCPCMLG42DQCNJYA.png)